Open Access Research article

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, Antonella Dal Mas, Gino Coletti, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2012, 10:135  doi:10.1186/1741-7015-10-135

Article Metrics

2819
Total accesses


1
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 60 accesses
  • Last 365 days: 817 accesses
  • All time: 2819 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by

BioMed Central: 1 citation